Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products | Synapse
March 3, 2026
Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products
AM
Armen H. Mekhdjian
MS
Morteza Sarmadi
IO
Isabel Olson
Ver todo
Puntos clave
Ascorbic acid effectively reduces nitrosamines, improving drug product safety and stability.
The study noted a significant decrease in nitrosamine levels, with a 50% reduction after ascorbic acid incorporation.
Assessment of the impact on stability and reactivity was carried out using controlled experiments.
These findings may indicate potential improvements in pharmaceutical formulations for broader applications.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Mekhdjian et al. (Thu,) studied this question.
synapsesocial.com/papers/69a7679cbadf0bb9e87e1a39
https://doi.org/https://doi.org/10.1016/j.xphs.2026.104190
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir